Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
E-Qure Corp is a medical device company, which established for the purpose of acquiring certain of IP (intellectual property) assets pertaining to a wound healing device. The company owns IP assets which include wound healing device which is designed for wound treatment incorporating Bioelectrical Signal Therapy (BST Device). BST Device is used to treat severe stage II, as well as stage III and IV wounds, including pressure ulcers, diabetic ulcers, and venous ulcers.
New York, NY, 10023